Hualiang Xiao

4.6k total citations · 1 hit paper
77 papers, 3.2k citations indexed

About

Hualiang Xiao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hualiang Xiao has authored 77 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 26 papers in Molecular Biology. Recurrent topics in Hualiang Xiao's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (9 papers) and Cancer Cells and Metastasis (6 papers). Hualiang Xiao is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (9 papers) and Cancer Cells and Metastasis (6 papers). Hualiang Xiao collaborates with scholars based in China, United States and United Kingdom. Hualiang Xiao's co-authors include Xiu‐Wu Bian, You‐Hong Cui, Shi‐Cang Yu, Yi‐Fang Ping, Yi Liang, Xian-Zong Ye, Senlin Xu, Cheng Qian, Qingya Luo and Yi Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hualiang Xiao

76 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation

2020 530 citations Tao Liu, Qinglv Wei et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hualiang Xiao China	27	1.8k	1.1k	993	554	461	77	3.2k
Marta Pàez‐Ribes United Kingdom	15	1.9k 1.1×	1000 0.9×	1.1k 1.1×	465 0.8×	452 1.0×	18	3.2k
Logan A. Walsh Canada	26	1.7k 1.0×	979 0.9×	1.1k 1.1×	697 1.3×	429 0.9×	55	3.4k
Anoop P. Patel United States	16	2.2k 1.2×	1.4k 1.3×	1.3k 1.3×	699 1.3×	349 0.8×	35	3.6k
Ruli Gao United States	18	1.8k 1.0×	1.0k 1.0×	1.5k 1.5×	407 0.7×	353 0.8×	31	2.8k
Mario L. Suvà United States	21	3.2k 1.8×	947 0.9×	1.4k 1.4×	559 1.0×	392 0.9×	47	4.4k
Anhua Wu China	33	1.4k 0.8×	993 0.9×	852 0.9×	885 1.6×	642 1.4×	132	3.5k
Tathiane M. Malta Brazil	15	2.0k 1.1×	768 0.7×	1.2k 1.2×	410 0.7×	884 1.9×	37	3.1k
Yi‐Fang Ping China	34	1.9k 1.1×	1.4k 1.3×	1.2k 1.2×	929 1.7×	226 0.5×	70	3.7k
Florian Scherer Germany	12	1.6k 0.9×	1.1k 1.0×	1.5k 1.5×	789 1.4×	1.0k 2.2×	45	3.5k

Countries citing papers authored by Hualiang Xiao

Since Specialization

Citations

This map shows the geographic impact of Hualiang Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hualiang Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hualiang Xiao more than expected).

Fields of papers citing papers by Hualiang Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hualiang Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hualiang Xiao. The network helps show where Hualiang Xiao may publish in the future.

Co-authorship network of co-authors of Hualiang Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Hualiang Xiao. A scholar is included among the top collaborators of Hualiang Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hualiang Xiao. Hualiang Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Shuo, Weihua Lan, Yapeng Wang, et al.. (2024). Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Medicine. 13(21). e70398–e70398. 1 indexed citations

Huang, Pan, Qiang Ma, Lianhua Zhao, et al.. (2024). Prediction of PD-L1 tumor positive score in lung squamous cell carcinoma with H&E staining images and deep learning. Frontiers in Artificial Intelligence. 7. 1452563–1452563.

Zhong, Peng, et al.. (2023). Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma. International Journal of Surgical Pathology. 32(4). 758–766. 3 indexed citations

Zheng, Nan, Yimin Zhang, Qiang Ma, et al.. (2023). Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer. Targeted Oncology. 18(4). 625–636. 5 indexed citations

Han, Rui, Yimin Zhang, Tianhu Wang, et al.. (2023). Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer. Cancer Science. 114(6). 2569–2583. 13 indexed citations

Huang, Pan, Xiaoli Zhou, Peng He, et al.. (2022). Interpretable laryngeal tumor grading of histopathological images via depth domain adaptive network with integration gradient CAM and priori experience-guided attention. Computers in Biology and Medicine. 154. 106447–106447. 21 indexed citations

Huang, Pan, Peng He, Sukun Tian, et al.. (2022). A ViT-AMC Network With Adaptive Model Fusion and Multiobjective Optimization for Interpretable Laryngeal Tumor Grading From Histopathological Images. IEEE Transactions on Medical Imaging. 42(1). 15–28. 64 indexed citations

Liu, Tao, Qinglv Wei, Jing Jin, et al.. (2020). The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Research. 48(7). 3816–3831. 530 indexed citations breakdown →

Liu, Qiuli, Jian Pang, Jing Xu, et al.. (2020). Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2. The Journal of Pathology. 253(1). 106–118. 48 indexed citations

10.

Wang, Qiushi, et al.. (2020). RBBP6 induces non‑small cell lung cancer cell proliferation and high expression is associated with poor prognosis. Oncology Letters. 19(4). 2895–2901. 7 indexed citations

11.

Xiao, Hualiang, Qian Cheng, Xiaoyan Wu, et al.. (2019). ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Shi, Yu, Cong Chen, Shizhu Yu, et al.. (2015). miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Clinical Cancer Research. 21(17). 4004–4013. 49 indexed citations

13.

Wang, Qiushi, Xin Yang, Yong He, et al.. (2015). Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma. Journal of Molecular Diagnostics. 17(5). 515–520. 22 indexed citations

14.

Deng, Moyuan, Peng Liu, Hualiang Xiao, et al.. (2015). Improving the osteogenic efficacy of BMP2 with mechano growth factor by regulating the signaling events in BMP pathway. Cell and Tissue Research. 361(3). 723–731. 12 indexed citations

15.

Li, Li, Rui Han, Hualiang Xiao, et al.. (2014). Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal. Clinical Cancer Research. 20(10). 2714–2726. 204 indexed citations

16.

Zhang, Lei, Zhiqiang Wang, Heng Ge, et al.. (2013). Effect of intra-abdominal volume increment on lungs in hemorrhagic shock. Bratislavské lekárske listy/Bratislava medical journal. 114(8). 425–430. 1 indexed citations

17.

Wang, Yi, Hualiang Xiao, Ying Jia, et al.. (2012). Pulmonary adenofibroma in a middle-aged man: report of a case. Surgery Today. 43(6). 690–693. 10 indexed citations

18.

Guo, Wei, Hualiang Xiao, Yao‐Guang Jiang, et al.. (2011). Retrospective analysis for thirty-nine patients with solitary fibrous tumor of pleura and review of the literature. World Journal of Surgical Oncology. 9(1). 134–134. 20 indexed citations

19.

Liang, Yi, Hualiang Xiao, Minhui Xu, et al.. (2010). Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma. Journal of Neuroimmunology. 232(1-2). 75–82. 126 indexed citations

20.

Bian, Xiu‐Wu, Jianhong Chen, Yi‐Fang Ping, et al.. (2007). PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL. Neurosurgery. 61(3). 570–579. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact